FDA Import Refusal AEK-8036235-0/11/1 — Boehringer Ingelheim India Pvt Ltd
The FDA refused shipment AEK-8036235-0/11/1 from Boehringer Ingelheim India Pvt Ltd (India) on Nov 20, 2020. The refused product falls under Drugs and Biologics — LINAGLIPTIN (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Nov 20, 2020
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61PDB66 LINAGLIPTIN (ANTI-DIABETIC)
- Charges
- 75